Cargando…

Bias and inconsistency in the estimation of tumour mutation burden

BACKGROUND: Tumour mutation burden (TMB), defined as the number of somatic mutations per megabase within the sequenced region in the tumour sample, has been used as a biomarker for predicting response to immune therapy. Several studies have been conducted to assess the utility of TMB for various can...

Descripción completa

Detalles Bibliográficos
Autores principales: Makrooni, Mohammad A., O’Sullivan, Brian, Seoighe, Cathal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347149/
https://www.ncbi.nlm.nih.gov/pubmed/35918650
http://dx.doi.org/10.1186/s12885-022-09897-3

Ejemplares similares